News
AZ makes another cell therapy play with $1.2bn Gracell buy
AstraZeneca has lined up a $1.2 billion takeover deal for Chinese …
19760 items found
R&D
Exploring the reasons behind increasing burdens on clinical research sites
In the first of a five-part festive instalment of the pharmaphorum …
R&D
Investing in healthspan: A prescription for prosperity
The combined efforts of researchers, investors, and pharmaceutical …
News
BMS wagers $14bn on Karuna’s schizophrenia drug
Bristol-Myers Squibb has decided to gamble on the FDA approving …
Patients
3 ways to make 2024 the year of the patient
Clinical research is never just about the next year; it's always …
News
FDA approves Ionis, AZ’s Wainua for ATTR polyneuropathy
AstraZeneca and Ionis are planning a US launch next month for Wainua, …
Digital
AI and the human touch: Embracing a symbiotic future
How long is your current to-do list? In today’s hyper-paced digital …
News
A look back at 2023: Smith + Nephew
This year brought about a whole gambit of news and developments, of …
News
AI specialist Fauna grabs $494m Lilly obesity alliance
A US biotech that is trying to find new avenues for treating human …
News
Let’s Talk Prostate Cancer calls for action by MEPs
An organisation representing the interests of patients with prostate …
News
Servier facing €431m penalties in new Mediator judgment
The Paris Court of Appeals has handed down its judgment against …
Digital
Top 5 Takeaways from Frontiers Health 2023
On 8th November, Healthware Group and EVERSANA invited some of the …
Oncology
Juggling CMC trade-offs with personalised cancer vaccines
Personalised cancer vaccines offer significant potential to address an unmet medical need in treatment-resistant disease with fewer side effects and less toxicity compared to standard treat
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
